It has been shown that the elevated expression of GRP78 is correlated with cancer malignancy, metastasis, and drug resistance in a variety of cancers, including breast cancer, prostate cancer, lung cancer, and glioma [96]. This evidence concerns the gene HSPA5 and breast cancer.